| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding metabolic agents to prostate cancer therapy: Every rose has its thorn
|
Buck, Stefan A.J.
|
|
|
170 |
C |
p. 305-307
|
artikel
|
| 2 |
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysis
|
Simon, Sandy
|
|
|
170 |
C |
p. 169-178
|
artikel
|
| 3 |
Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response
|
Choi, Sangjoon
|
|
|
170 |
C |
p. 17-26
|
artikel
|
| 4 |
Augmented reality-guided localization of a chest wall tumor in a pediatric patient
|
Spijkerboer, Koen G.P.
|
|
|
170 |
C |
p. 103-105
|
artikel
|
| 5 |
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
|
Machingura, Abigirl
|
|
|
170 |
C |
p. 1-9
|
artikel
|
| 6 |
Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma
|
Petzold, Anne
|
|
|
170 |
C |
p. 42-53
|
artikel
|
| 7 |
Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis
|
Ajani, Jaffer A.
|
|
|
170 |
C |
p. 119-130
|
artikel
|
| 8 |
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
|
Wilson, Brooke E.
|
|
|
170 |
C |
p. 296-304
|
artikel
|
| 9 |
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|
Garbe, Claus
|
|
|
170 |
C |
p. 236-255
|
artikel
|
| 10 |
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|
Garbe, Claus
|
|
|
170 |
C |
p. 256-284
|
artikel
|
| 11 |
Immune contexture of paediatric cancers
|
Thakur, Meghna Das
|
|
|
170 |
C |
p. 179-193
|
artikel
|
| 12 |
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data
|
Albiges, Laurence
|
|
|
170 |
C |
p. 158-168
|
artikel
|
| 13 |
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations
|
Piaggio, Francesca
|
|
|
170 |
C |
p. 27-41
|
artikel
|
| 14 |
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma
|
Budde, Axel
|
|
|
170 |
C |
p. 209-235
|
artikel
|
| 15 |
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials
|
Liu, Drolaiz H.W.
|
|
|
170 |
C |
p. 140-148
|
artikel
|
| 16 |
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study
|
Roubaud, Guilhem
|
|
|
170 |
C |
p. 73-84
|
artikel
|
| 17 |
Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls
|
Amant, Frédéric
|
|
|
170 |
C |
p. 54-63
|
artikel
|
| 18 |
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry
|
Cortellini, Alessio
|
|
|
170 |
C |
p. 10-16
|
artikel
|
| 19 |
Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening
|
Delaye, Matthieu
|
|
|
170 |
C |
p. 85-90
|
artikel
|
| 20 |
Re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
|
Kong, Lingti
|
|
|
170 |
C |
p. 194-195
|
artikel
|
| 21 |
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER
|
Joshua, Anthony M.
|
|
|
170 |
C |
p. 285-295
|
artikel
|
| 22 |
Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma
|
Windsor, Rachael
|
|
|
170 |
C |
p. 131-139
|
artikel
|
| 23 |
Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours
|
Schubert, Nil A.
|
|
|
170 |
C |
p. 196-208
|
artikel
|
| 24 |
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions
|
Christopoulos, Petros
|
|
|
170 |
C |
p. 106-118
|
artikel
|
| 25 |
The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancer
|
Pino, Maria S.
|
|
|
170 |
C |
p. 149-157
|
artikel
|
| 26 |
The regulation of CD73 in non-small cell lung cancer
|
Han, Yumin
|
|
|
170 |
C |
p. 91-102
|
artikel
|
| 27 |
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies
|
Rossini, Daniele
|
|
|
170 |
C |
p. 64-72
|
artikel
|
Tijdschrift beschrijving